Boehringer Ingelheim: Christine Sakdalan and Mike Jablonski talk precision psychiatry

Power to the Patients

Apr 09 2025 | 00:40:32

00:00 / 00:40:32

Show Notes

In this episode of Power to the Patients, Boehringer Ingelheim leaders Christine Sakdalan and Mike Jablonski from discuss how precision psychiatry—using tools like biomarkers and neuroimaging—can personalize treatment for conditions like schizophrenia and depression. They highlight the importance of holistic care, digital therapeutics, and industry collaboration to address unmet needs and improve outcomes in mental health.

Other Episodes

Episode 12

February 07, 2025 • 00:33:20

From Culture to Care: The Framework of Patient Centricity

How do we move from a system that treats disease to a system that cares for individuals? Dr. Anthony Yanni, Senior Vice President and...

Episode

December 27, 2023 • 00:43:13

Patient-first Approaches in Clinical Trials with Megan Liles

Explore the world of clinical trials with our guest, Megan Liles. Drawing from her 25+ years of experience, Megan offers a practical perspective on...

Episode 1

September 19, 2024 • 00:38:43

Psychedelics and the Future of Anxiety Relief

In this episode, Dr. Dan Karlin, Chief Medical Officer at MindMed, talks about the potential of psychedelic therapies, especially LSD, to help treat anxiety....